Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Transgender clinical trials

2 of 5 indexed Transgender trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Transgender: 5 US clinical trials tracked, 2 recruiting.

Transgender is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is University of Pittsburgh, running 2 of these trials.

Enrollment posture brief

Registry condition transgender

OPEN 2 | RECR 40% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Transgender (this)40%
Open-enrollment share among volume-matched conditions near Transgender

Transgender lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Transgender on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Transgender is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Transgender research.

    University of Pittsburgh accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Transgender trials plan to enrol fewer than 100 people.

    Median target enrolment is 90 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Transgender research leans observational.

    0 interventional and 5 observational studies make up this index (0% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

University of Pittsburgh 2 trials
University of Colorado, Denver 1 trials
University of Minnesota 1 trials
Medical College of Wisconsin 1 trials

Named interventions

Most-linked intervention names on Transgender records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Infectious Disease Testing Diagnostic test
2 trials
Gonadal Tissue Removal Procedure
1 trials
Oophorectomy Procedure
1 trials
Testosterone Drug
1 trials
No intervention Other
1 trials

US sites by state

Facility locations filed on Transgender trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Wisconsin 1 trials
Minnesota 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Transgender page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Transgender condition card totals 5 registered trials; most-linked intervention Infectious Disease Testing; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.